Your browser doesn't support javascript.
loading
Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer.
Facciotto, Chiara; Casado, Julia; Turunen, Laura; Leivonen, Suvi-Katri; Tumiati, Manuela; Rantanen, Ville; Kauppi, Liisa; Lehtonen, Rainer; Leppä, Sirpa; Wennerberg, Krister; Hautaniemi, Sampsa.
Afiliação
  • Facciotto C; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, PO Box 63, Helsinki, Finland.
  • Casado J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, PO Box 63, Helsinki, Finland.
  • Turunen L; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Leivonen SK; Department of Oncology, Helsinki University Hospital Cancer Center, Helsinki, Finland.
  • Tumiati M; Research Program in Applied Tumor Genetics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Rantanen V; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, PO Box 63, Helsinki, Finland.
  • Kauppi L; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, PO Box 63, Helsinki, Finland.
  • Lehtonen R; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, PO Box 63, Helsinki, Finland.
  • Leppä S; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, PO Box 63, Helsinki, Finland.
  • Wennerberg K; Department of Oncology, Helsinki University Hospital Cancer Center, Helsinki, Finland.
  • Hautaniemi S; Research Program in Applied Tumor Genetics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Clin Epigenetics ; 11(1): 192, 2019 12 11.
Article em En | MEDLINE | ID: mdl-31829282
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Linfoma Difuso de Grandes Células B / Resistencia a Medicamentos Antineoplásicos / Epigênese Genética / Inibidores Enzimáticos / Rituximab Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Humans Idioma: En Revista: Clin Epigenetics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doxorrubicina / Linfoma Difuso de Grandes Células B / Resistencia a Medicamentos Antineoplásicos / Epigênese Genética / Inibidores Enzimáticos / Rituximab Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Humans Idioma: En Revista: Clin Epigenetics Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Finlândia